Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 32% ± 12% | |
peripheral blood | 12 studies | 24% ± 7% | |
intestine | 11 studies | 25% ± 11% | |
kidney | 8 studies | 28% ± 6% | |
brain | 8 studies | 26% ± 12% | |
heart | 5 studies | 21% ± 3% | |
breast | 5 studies | 27% ± 9% | |
liver | 5 studies | 33% ± 9% | |
pancreas | 4 studies | 46% ± 19% | |
placenta | 4 studies | 38% ± 15% | |
prostate | 4 studies | 34% ± 13% | |
bone marrow | 3 studies | 21% ± 3% | |
eye | 3 studies | 24% ± 4% | |
uterus | 3 studies | 31% ± 17% | |
esophagus | 3 studies | 40% ± 22% | |
skin | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 57726.12 | 226 / 226 | 100% | 269.02 | 406 / 406 |
pancreas | 100% | 33883.52 | 328 / 328 | 100% | 200.17 | 178 / 178 |
thymus | 100% | 42773.36 | 653 / 653 | 100% | 282.60 | 605 / 605 |
uterus | 100% | 24035.35 | 170 / 170 | 100% | 192.45 | 459 / 459 |
prostate | 100% | 36028.45 | 245 / 245 | 100% | 209.61 | 501 / 502 |
kidney | 100% | 41693.89 | 89 / 89 | 100% | 299.85 | 898 / 901 |
intestine | 100% | 30992.62 | 966 / 966 | 100% | 161.26 | 525 / 527 |
adrenal gland | 100% | 73601.80 | 258 / 258 | 100% | 202.96 | 229 / 230 |
lung | 100% | 25788.02 | 576 / 578 | 100% | 144.60 | 1152 / 1155 |
stomach | 100% | 28814.94 | 359 / 359 | 99% | 131.13 | 284 / 286 |
breast | 100% | 32043.18 | 459 / 459 | 99% | 148.74 | 1108 / 1118 |
bladder | 100% | 28461.29 | 21 / 21 | 99% | 207.30 | 499 / 504 |
esophagus | 100% | 27417.55 | 1444 / 1445 | 99% | 107.89 | 181 / 183 |
ovary | 100% | 22558.39 | 180 / 180 | 98% | 97.57 | 423 / 430 |
skin | 99% | 19478.20 | 1784 / 1809 | 100% | 149.73 | 470 / 472 |
brain | 97% | 12816.28 | 2559 / 2642 | 100% | 149.41 | 705 / 705 |
adipose | 100% | 28701.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 127.59 | 29 / 29 |
muscle | 100% | 54440.80 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 30997.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 179.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 95.78 | 1 / 1 |
blood vessel | 99% | 16510.35 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 45201.09 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 140.51 | 78 / 80 |
peripheral blood | 88% | 10268.27 | 815 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090181 | Biological process | regulation of cholesterol metabolic process |
GO_0015980 | Biological process | energy derivation by oxidation of organic compounds |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0009409 | Biological process | response to cold |
GO_0046322 | Biological process | negative regulation of fatty acid oxidation |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0033539 | Biological process | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
GO_0001659 | Biological process | temperature homeostasis |
GO_0005730 | Cellular component | nucleolus |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0017099 | Molecular function | very-long-chain fatty acyl-CoA dehydrogenase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0004466 | Molecular function | long-chain fatty acyl-CoA dehydrogenase activity |
GO_0003995 | Molecular function | acyl-CoA dehydrogenase activity |
GO_0000062 | Molecular function | fatty-acyl-CoA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACADVL |
Protein name | Acyl-CoA dehydrogenase very long chain Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.9) VLCAD (EC 1.3.8.8) Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9) |
Synonyms | VLCAD hCG_42007 |
Description | FUNCTION: Very long-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats . The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA . Among the different mitochondrial acyl-CoA dehydrogenases, very long-chain specific acyl-CoA dehydrogenase acts specifically on acyl-CoAs with saturated 12 to 24 carbons long primary chains . . |
Accessions | J3QRJ8 J3KS89 ENST00000583312.5 A0A077H1I5 ENST00000350303.9 [P49748-2] ENST00000583858.5 ENST00000579546.1 ENST00000322910.9 K7EJW8 K7EMF8 ENST00000543245.6 [P49748-3] J3QKU9 J3KSR4 ENST00000579886.2 K7EQP4 ENST00000583848.5 ENST00000356839.10 [P49748-1] ENST00000584103.5 ENST00000542255.6 J9JID6 P49748 ENST00000581378.5 G3V1M7 B3KPA6 |